- 【Updated on May 12, 2025】 Integration of CiNii Dissertations and CiNii Books into CiNii Research
- Trial version of CiNii Research Knowledge Graph Search feature is available on CiNii Labs
- Suspension and deletion of data provided by Nikkei BP
- Regarding the recording of “Research Data” and “Evidence Data”
A Long-term Complete Response(CR)for More Than 10 Years with Chemotherapy in a Patient with Breast Cancer and Liver Metastases
-
- OSANAI Takayuki
- Department of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation, Ohkubo Hospital
-
- SATO Eigo
- Department of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation, Ohkubo Hospital
-
- TOMI Yoshiaki
- Department of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation, Ohkubo Hospital
-
- MURAKATA Ayano
- Department of Surgery, Tokyo Metropolitan Health and Medical Treatment Corporation, Ohkubo Hospital
-
- ODA Goshi
- Department of Breast Surgery, Tokyo Medical and Dental University
Bibliographic Information
- Other Title
-
- 化学療法にて10年以上CRを得ている乳癌肝転移の1例
- 症例 化学療法にて10年以上CRを得ている乳癌肝転移の1例
- ショウレイ カガク リョウホウ ニテ 10ネン イジョウ CR オ エテ イル ニュウガン カン テンイ ノ 1レイ
Search this article
Description
A 53-year-old woman had a left breast mass at age 41 years noted by another physician, and further workup yielded a diagnosis of breast cancer (scirrhous carcinoma) : cT2 N1 (SLNB1/2) M0. She received neoadjuvant (preoperative) chemotherapy, underwent breast-conserving surgery, and then started adjuvant hormonal therapy (LHRH agonist + tamoxifen). At 1 year 5 months after starting hormonal therapy, a solitary 4-cm liver metastasis in S4 was noted. Anticancer therapy with weekly paclitaxel led to a complete response (CR), and then oral capecitabine was started at the patient's request. Currently, 12 years 9 months postoperatively (10 years 1 month after the liver metastasis was diagnosed), imaging studies have confirmed a long-term CR with no evidence of further metastases in any organ.<BR>In patients with oligometastases, even liver metastases in breast cancer, chemotherapy can have a favorable therapeutic effect in many cases. Oral anticancer drugs without established lifetime doses may help to maintain a long-term CR and should be considered as a therapeutic option.
Journal
-
- Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association)
-
Nihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association) 79 (8), 1609-1612, 2018
Japan Surgical Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390282763101574912
-
- NII Article ID
- 130007604531
-
- NII Book ID
- AA11189709
-
- ISSN
- 18825133
- 13452843
-
- NDL BIB ID
- 029254765
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- NDL Search
- Crossref
- CiNii Articles
- OpenAIRE
-
- Abstract License Flag
- Disallowed